Table 4.
ETG Pre | ETG Post | p * | CG Pre | CG Post | p * | Between Group Δ Post-Pre p † | Effect Size | |
---|---|---|---|---|---|---|---|---|
PWB | 20.5 [13.0–23.0] |
18.5 [15.0–24.0] |
<0.84 | 25.5 [22.0–28.0] |
19.5 [16.5–25.0] |
<0.02 | 0.02 | 0.753 |
SWB | 22.5 [18.0–25.0] |
20.0 [18.0–24.0] |
<0.40 | 25.5 [22.0–28.0] |
19.5 [16.5- 25.0] |
<0.93 | 0.64 | −0.459 |
EWB | 17.0 [8.0–22.0] |
16.5 [12.0–21.0] |
<0.94 | 24.5 [19.0- 25.5] |
23.5 [18.5–25.5] |
<0.34 | 0.50 | −0.524 |
FWB | 18.5 [16.0- 21.0] |
19.5 [15.0- 24.0] |
<0.56 | 17.5 [15.5–19.5] |
19.0 [15.5–22.0] |
<0.44 | 0.78 | −0.251 |
LC | 17.5 [16.0–24.0] |
22.5 [18.0–24.0] |
<0.17 | 17.5 [15.5–22.0] |
22.0 [15.5–5.0] |
<0.11 | 0.10 | 0.592 |
FACT-L | 91.0 [76.0–113.0] |
92.5 [77.0–108.0] |
<0.87 | 99.5 [95.5–118.0] |
106.0 [84.5–115.0] |
<0.22 | 0.49 | 0.058 |
PWB: physical well-being; SWB: social well-being; EWB: emotional well-being; FWB: functional well-being; LC: lung cancer; FACT-L: Functional Assessment of Cancer Therapy-Lung; *—within-group analysis (Wilcoxon signed-rank test); †—between-group analysis (Mann-Whitney U test).